1D
1.38%
0.58%
1W
0.27%
2.94%
1M
-3.25%
0.59%
YTD
-5.98%
-1.36%
1Y
-33.66%
7.97%
3Y
89.66%
38.25%
5Y
175%
63.78%
10Y
-25.8%
249.97%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.26%
0%
-8.26%
6 Months
13.7%
0%
13.7%
1 Year
-33.66%
0%
-33.66%
2 Years
-34.74%
0%
-34.74%
3 Years
89.66%
0%
89.66%
4 Years
74.6%
0%
74.6%
5 Years
175.0%
0%
175.0%
Beryl Drugs for the last several years.
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Underperformer
Beryl Drugs Ltd has been in the Third and Fourth Quartile in the last 1 year and longer periods
3
Quartile
QTD
-7.26%
3
Quartile
Sep-Dec
5.22%
2
Quartile
Jun-Sep
4.46%
4
Quartile
1Y
-34.56%
4
Quartile
2025
-35.27%
3
Quartile
2024
63.5%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Beryl Drugs Ltd has not been a consistent performer in the last 1 year and longer periods
3
Quartile
QTD
-7.26%
2
Quartile
Sep-Dec
5.22%
1
Quartile
Jun-Sep
4.46%
3
Quartile
1Y
-34.56%
3
Quartile
2025
-35.27%
2
Quartile
2024
63.5%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






